NCT01383161View on ClinicalTrials.gov

18-Month Study of Memory Effects of Curcumin

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Age-associated Cognitive ImpairmentMild Cognitive Impairment (MCI)
Interventions
DRUG

Curcumin

Six Theracurmin capsules (containing 30 mg of curcumin each) per day for 18 months.

OTHER

Placebo

Six capsules per day for 18 months.

Trial Locations (1)

90095

UCLA Longevity Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01383161 - 18-Month Study of Memory Effects of Curcumin | Biotech Hunter | Biotech Hunter